Effectiveness and Safety of Platelet Rich Plasma (PRP) on Persistent Olfactory Dysfunction Related to COVID-19

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

August 1, 2021

Study Completion Date

August 1, 2021

Conditions
AnosmiaCOVID-19
Interventions
DRUG

Platelet rich plasma (PRP)

PRP injections were performed in each olfactory cleft by nasal endoscopy and under local anesthesia, a sniffing stick test was performed before the injection and one month after

OTHER

olfactory training

"The investigators compare the result of the PRP group to a control group how underwent simple olfactive training for one month.~The control group matched for age, gender and olfactory score at baseline. The patients had a sniffing stick test at the beginning and also after one month of olfactory training."

Trial Locations (1)

1000

CHU saint pierre, Brussels

All Listed Sponsors
lead

Centre Hospitalier Universitaire Saint Pierre

OTHER

NCT05226546 - Effectiveness and Safety of Platelet Rich Plasma (PRP) on Persistent Olfactory Dysfunction Related to COVID-19 | Biotech Hunter | Biotech Hunter